Grifols SA
Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols i Roig in 1909 and is headquartered in Barcelona, Spain.
What If You Bought GRFS Earlier?
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Jan 4, 2016 | $16.20 | 2-for-1 | 2× | 2.1× |
| Dec 11, 2012 | $11.62 | 21-for-20 | 1.05× | 1.05× |
Grifols SA Market Cap Timeline
Validated annual market-cap history is available from 2008. Split markers cover all 2 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.